Abstract
In the present study we report that 4,5-dihydroxy-2-cyclopentan-1-one (DHCP), which is derived from heat-treatment of uronic acid or its derivatives, has antibacterial activity against Escherichia coli. The compound causes complete growth inhibition at 350 microM concentration. We have cloned a gene from E. coli, which confers DHCP resistance when present in multicopy. The putative protein encoded by this gene (dep- DHCP efflux protein) is a transmembrane efflux protein with a high homology to other antibiotic-efflux proteins including those for chloramphenicol, bicyclomycin and tetracycline. However, the Dep protein does not confer cross-resistance to any of the antibiotics tested.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amino Acid Sequence
-
Anti-Bacterial Agents / pharmacology*
-
Bacterial Proteins / chemistry
-
Bacterial Proteins / genetics*
-
Carrier Proteins / chemistry
-
Cloning, Molecular
-
Cyclopentanes / pharmacology*
-
Drug Resistance, Microbial / genetics*
-
Escherichia coli / drug effects*
-
Escherichia coli / genetics*
-
Escherichia coli / growth & development
-
Escherichia coli Proteins*
-
Genomic Library
-
Kinetics
-
Membrane Proteins / chemistry
-
Membrane Transport Proteins*
-
Molecular Sequence Data
-
Peptide Library
-
Protein Conformation
-
Sequence Alignment
-
Sequence Homology, Amino Acid
-
Software
Substances
-
4,5-dihydroxy-2-cyclopentan-1-one
-
Anti-Bacterial Agents
-
Bacterial Proteins
-
Carrier Proteins
-
Cyclopentanes
-
Escherichia coli Proteins
-
Mdfa protein, E coli
-
Membrane Proteins
-
Membrane Transport Proteins
-
Peptide Library
-
dep-DHCP efflux protein, E coli